Next Article in Journal
Trends in Prevalence and Incidence of Epilepsy and Drug-Resistant Epilepsy in Children: A Nationwide Population-Based Study in Korea
Previous Article in Journal
Long Neurocognitive and Neuropsychiatric Sequelae in Participants with Post-COVID-19 Infection: A Longitudinal Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Clinical Case of a 23-Year-Old Patient with Moyamoya Disease and Epilepsy in Bulgaria

1
Department of Neurology, Faculty of Medicine, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria
2
Clinic of Neurology, UMHAT “Sv. Georgi”, 4000 Plovdiv, Bulgaria
3
Medical Faculty, Sofia University St. Kliment Ohridski, 1 Kozyak Str., 1407 Sofia, Bulgaria
*
Author to whom correspondence should be addressed.
Neurol. Int. 2024, 16(4), 869-879; https://doi.org/10.3390/neurolint16040065
Submission received: 1 July 2024 / Revised: 10 August 2024 / Accepted: 14 August 2024 / Published: 20 August 2024

Abstract

Moyamoya disease is a cerebrovascular pathology characterized by progressive stenosis of the internal carotid arteries and their branches, leading to ischemic and/or hemorrhagic disorders of the cerebral circulation, primarily affecting children and young adults. We present a case of a 23-year-old woman with a history of recurrent cerebrovascular accidents since childhood. Despite experiencing focal motor seizures and transient ischemic attacks, her condition remained undiagnosed until 2006, when, at the age of 7, a digital subtraction angiography revealed characteristic bilateral internal carotid artery occlusions. Subsequent diagnostic challenges and treatments preceded a worsening of symptoms in adulthood, including generalized tonic–clonic seizures. Upon presentation to our clinic, the patient exhibited upper motor neuron syndrome and occipital lobe syndrome, consistent with the disease’s pathophysiology, neuroimaging, and clinical manifestations. Imaging studies confirmed multiple ischemic lesions throughout the cerebral vasculature. Treatment adjustments were made due to the increased incidence of seizures, and the dose of her anti-seizure medication—divalproex sodium—was increased. This case underscores the diagnostic complexities and challenges in managing moyamoya disease, emphasizing the importance of early recognition and prompt intervention.
Keywords: cerebral vasculopathy; moyamoya; ischemic stroke in young age; transient ischemic attack cerebral vasculopathy; moyamoya; ischemic stroke in young age; transient ischemic attack

Share and Cite

MDPI and ACS Style

Viteva, E.; Vasilev, P.; Vasilev, G.; Chompalov, K. Clinical Case of a 23-Year-Old Patient with Moyamoya Disease and Epilepsy in Bulgaria. Neurol. Int. 2024, 16, 869-879. https://doi.org/10.3390/neurolint16040065

AMA Style

Viteva E, Vasilev P, Vasilev G, Chompalov K. Clinical Case of a 23-Year-Old Patient with Moyamoya Disease and Epilepsy in Bulgaria. Neurology International. 2024; 16(4):869-879. https://doi.org/10.3390/neurolint16040065

Chicago/Turabian Style

Viteva, Ekaterina, Petar Vasilev, Georgi Vasilev, and Kostadin Chompalov. 2024. "Clinical Case of a 23-Year-Old Patient with Moyamoya Disease and Epilepsy in Bulgaria" Neurology International 16, no. 4: 869-879. https://doi.org/10.3390/neurolint16040065

APA Style

Viteva, E., Vasilev, P., Vasilev, G., & Chompalov, K. (2024). Clinical Case of a 23-Year-Old Patient with Moyamoya Disease and Epilepsy in Bulgaria. Neurology International, 16(4), 869-879. https://doi.org/10.3390/neurolint16040065

Article Metrics

Back to TopTop